Electronic Resource

A Phase 1/2 Trial of a Tetravalent Live-Attenuated Dengue Vaccine in Flavivirus-Naive Thai Infants

التفاصيل البيبلوغرافية
العنوان: A Phase 1/2 Trial of a Tetravalent Live-Attenuated Dengue Vaccine in Flavivirus-Naive Thai Infants
المؤلفون: PHRAMONGKUTKLAO HOSPITAL BANGKOK (THAILAND), Watanaveeradej, V., Kerdpanich, A., Samakoses, R., Tanakijaru, K., Aree, C., Simasathien, S., Mammen, M. P., Nisalak, A., Hengprasert, S., Jarman, R. J., Gibbons, R. V., Innis, B. L., Hutagalung, Y., Chunsuttiwat, S., Sun, W., Endy, T. P., Thomas, S., Eckels, K. H., Putnak, R., Vaughn, D. W.
المصدر: DTIC
بيانات النشر: 2006-11
نوع الوثيقة: Electronic Resource
مستخلص: The Walter Reed Army Institute of Research (WRAIR) has produced a tetravalent live-attenuated dengue vaccine that has been well tolerated and immunogenic in U.S. adults and Thai children. As infants are considered by many as an important age group for vaccination in dengue-endemic countries, we evaluated the vaccine in Thai flavivirus-na ve infants who are at risk for dengue.
See also ADM002075., The original document contains color images. Presented at the Army Science Conference (25th) held in Orlando, FL on 27-30 November 2006.
مصطلحات الفهرس: Medicine and Medical Research, Pharmacology, VACCINES, INFANTS, DENGUE, IMMUNIZATION, THAILAND, FOREIGN REPORTS, FLAVIVIRUS-NAIVE, Text
URL: https://apps.dtic.mil/docs/citations/ADA481707
الاتاحة: Open access content. Open access content
Approved for public release; distribution is unlimited.
ملاحظة: text/html
English
Other Numbers: DTICE ADA481707
832017282
المصدر المساهم: From OAIster®, provided by the OCLC Cooperative.
رقم الانضمام: edsoai.ocn832017282
قاعدة البيانات: OAIster